MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 78 filers reported holding MUSTANG BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $21,372 | +130.3% | 58,295 | +148.1% | 0.00% | – |
Q4 2022 | $9,280 | +54.7% | 23,500 | +71.5% | 0.00% | – |
Q3 2022 | $6,000 | -98.4% | 13,700 | -97.8% | 0.00% | – |
Q2 2022 | $371,000 | +217.1% | 634,465 | +448.2% | 0.00% | – |
Q1 2022 | $117,000 | -66.5% | 115,742 | -44.9% | 0.00% | – |
Q4 2021 | $349,000 | -48.1% | 210,169 | -15.9% | 0.00% | – |
Q3 2021 | $672,000 | -36.8% | 249,848 | -22.0% | 0.00% | – |
Q2 2021 | $1,064,000 | +21.0% | 320,326 | +20.9% | 0.00% | – |
Q1 2021 | $879,000 | -39.0% | 265,029 | -30.4% | 0.00% | – |
Q4 2020 | $1,442,000 | +23.8% | 380,909 | +3.0% | 0.00% | – |
Q3 2020 | $1,165,000 | +284.5% | 369,920 | +288.8% | 0.00% | – |
Q2 2020 | $303,000 | +107.5% | 95,142 | +75.0% | 0.00% | – |
Q1 2020 | $146,000 | -15.6% | 54,365 | +28.1% | 0.00% | – |
Q4 2019 | $173,000 | +113.6% | 42,433 | +69.3% | 0.00% | – |
Q3 2019 | $81,000 | +92.9% | 25,064 | +119.7% | 0.00% | – |
Q2 2019 | $42,000 | +23.5% | 11,409 | -1.4% | 0.00% | – |
Q4 2018 | $34,000 | -63.4% | 11,570 | -26.2% | 0.00% | – |
Q3 2018 | $93,000 | – | 15,669 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
EMFO, LLC | 32,000 | $32,000 | 0.03% |
B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |